Clinical Evaluation of the Tiaoshen Anti-Cancer Regimen in Treating Psycho-Neurological Symptom Cluster in Ovarian Cancer

NANot yet recruitingINTERVENTIONAL
Enrollment

316

Participants

Timeline

Start Date

October 6, 2025

Primary Completion Date

September 1, 2028

Study Completion Date

November 30, 2028

Conditions
CancerCancer Symptom Clusters
Interventions
DRUG

Compound Ciwujia Granules

In addition to standard treatment protocol for ovarian cancer combined with psychological intervention, Compound Ciwujia Granules were administered at a dosage of one sachet twice daily for a treatment duration of 3 months.

DRUG

Placebo granules

In addition to standard treatment protocol for ovarian cancer combined with psychological intervention, placebo granules which containing 10% of Compound Ciwujia Granules drug were administered at a dosage of one sachet twice daily for a treatment duration of 3 months.

COMBINATION_PRODUCT

Standard treatment protocol for ovarian cancer combined with psychological intervention.

Standard treatment protocol for ovarian cancer: In accordance with the 2024 NCCN International Guidelines, patients opt for chemotherapy regimens containing platinum-based drugs and/or targeted therapy, anti-angiogenic therapy, hormonal therapy, etc. Psychological intervention is conducted once a week in the form of online and offline patient education sessions for psychological intervention, continuing until the end of the study period. Both the intervention group and the control group use this as the baseline treatment plan.

All Listed Sponsors
collaborator

Guangdong Provincial Hospital of Traditional Chinese Medicine

OTHER

collaborator

Affiliated Hospital of Qinghai University

OTHER

collaborator

Obstetrics & Gynecology Hospital of Fudan University

OTHER

collaborator

Fudan University

OTHER

collaborator

Beijing Hospital of Traditional Chinese Medicine

OTHER

lead

Shanghai Municipal Hospital of Traditional Chinese Medicine

OTHER